Commentary on Redefining Depression Management with Updated Treatment Strategies

Key Takeaways

Pediatric psoriasis demands tailored therapeutic approaches, considering growth, development, and treatment tolerability.
Limited treatment options due to safety concerns necessitate careful selection and monitoring in children.
The psychosocial impact on children, including stigma and quality of life, requires comprehensive management strategies.
Collaboration with caregivers and multidisciplinary teams is essential for effective management of pediatric psoriasis.

A panel of depressive disorder experts examines the need for updated APA treatment guidelines related to major depressive disorder, highlighting the roles of pharmacotherapy, psychotherapy, and combination therapy based on severity.

EP: 1.Expert Insights into Navigating MDD Prevalence, Stigma, and Treatment Challenges for Improved Patient Outcomes

EP: 2.Advancing MDD Treatment: From STAR*D Insights to Precision Medicine and Novel Therapeutics

Now Viewing

EP: 3.Commentary on Redefining Depression Management with Updated Treatment Strategies

EP: 4.Navigating Non-Response: A Holistic Approach to Patient Care

EP: 5.Transforming MDD: A Patient's Journey with Rapid-Acting Therapy

EP: 6.Quantifying Success: Measuring Depth of Treatment Response in MDD

EP: 7.Access Challenges: Bridging Insurance Gaps for MDD Innovations

EP: 8.Examining Molecular Differences in PDE4 Inhibitors in Pediatric Patients with Plaque Psoriasis

Video content above is prompted by the following:

In your experience, what are the unique challenges in managing psoriasis in children compared to adults?